CIK 0001771706 · Pharmaceutical Preparations (SIC 2834) · OTC · incorporated in A1 · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue (USD) | 268.8 M | 88.1 M | 74.6 M |
| Net income (USD) | -68.1 M | -25.5 M | -42.5 M |
| Diluted EPS (USD/shares) | -0.09 | -0.19 | -0.33 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-09 | S-4 | S-4 | |
| 2026-10-08 | 8-K | FORM 8-K items 1.01,1.02,2.03,7.01,9.01 | 2026-10-02 |
| 2026-10-07 | D | D items 06b | |
| 2026-10-02 | D | D items 06b | |
| 2026-08-28 | 425 | 425 | |
| 2026-08-26 | 8-K | FORM 8-K items 2.01,3.02,7.01,9.01 | 2026-08-21 |
| 2026-08-26 | 425 | 425 | |
| 2026-08-25 | 425 | 425 | |
| 2026-08-24 | D | D items 06b | |
| 2026-08-18 | 425 | 425 | |
| 2026-08-18 | 8-K | FORM 8-K items 7.01,8.01,9.01 | 2026-08-13 |
| 2026-08-18 | 425 | 425 | |
| 2026-08-14 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-13 | 425 | 425 | |
| 2026-08-13 | 425 | 425 | |
| 2026-08-13 | 8-K | FORM 8-K items 1.01,2.01,2.03,3.02,7.01,9.01 | 2026-08-07 |
| 2026-08-12 | 425 | 425 | |
| 2026-08-11 | 425 | 425 | |
| 2026-08-11 | 425 | 425 | |
| 2026-08-11 | 425 | 425 | |
| 2026-08-11 | 8-K | 8-K items 2.02,9.01 | 2026-08-11 |
| 2026-08-05 | 8-K | FORM 8-K items 1.01,7.01,8.01,9.01 | 2026-07-30 |
| 2026-07-30 | 425 | 425 | |
| 2026-07-30 | 8-K | FORM 8-K items 1.01,9.01 | 2026-07-26 |
| 2026-07-27 | 425 | 425 |
Forms on file (last 1,000): 8-K 89, 4 75, 424B3 29, 3 19, D 17, 10-Q 17, 425 13, CORRESP 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VREOF (0.002 USD), /gw/filings/filings?ticker=VREOF&form=8-K, /gw/filings/facts?ticker=VREOF&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange